Development of dermo-cosmetic products, pharmaceuticals for rheumatology, and natural cosmetic active ingredients.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: March 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Pierre Fabre
B
Development and marketing of dermo-cosmetic and pharmaceutical products, with a focus on skin and hair care, and therapeutic solutions in oncology and dermatology.
ISISPHARMA
A
Development and sale of dermatological and cosmetic products for various skin conditions.
IWASE COSFA
B
Research and development of cosmetic ingredients, material proposals, and distribution of functional foods and supplements.
Initiatives identified among leaders
Projets d’écoconception pour réduire l’impact environnemental des produits
“Le groupe Pierre Fabre mène des projets d’écoconce...” - Pierre FabreRéduction des émissions de Gaz à Effet de Serre
“ISISPHARMA a identifié quatre leviers d'action pri...” - ISISPHARMASystème de gestion éthique des fournisseurs avec évaluation et actions correctives.
“IWASE COSFA met en place un système de gestion des...” - IWASE COSFA56% of similar organizations communicate on CSR issues
+1302 initiatives collected from 48 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports